Rationale, design, and methodology for the optimizing outcomes in women with gestational diabetes mellitus and their infants study

Diane C. Berry, Madeline Neal, Emily G. Hall, Todd A. Schwartz, Sarah Verbiest, Karen A. Bonuck, William Goodnight, Seth Brody, Karen F. Dorman, Mary K. Menard, Alison M. Stuebe

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Background: Women who are diagnosed with gestational diabetes mellitus (GDM) are at increased risk for developing prediabetes and type 2 diabetes mellitus (T2DM). To date, there have been few interdisciplinary interventions that target predominantly ethnic minority low-income women diagnosed with GDM. This paper describes the rationale, design and methodology of a 2-year, randomized, controlled study being conducted in North Carolina.Methods/Design: Using a two-group, repeated measures, experimental design, we will test a 14- week intensive intervention on the benefits of breastfeeding, understanding gestational diabetes and risk of progression to prediabetes and T2DM, nutrition and exercise education, coping skills training, physical activity (Phase I), educational and motivational text messaging and 3 months of continued monthly contact (Phase II). A total of 100 African American, non-Hispanic white, and bilingual Hispanic women between 22-36 weeks of pregnancy who are diagnosed with GDM and their infants will be randomized to either the experimental group or the wait-listed control group. The first aim of the study is to determine the feasibility of the intervention. The second aim of study is to test the effects of the intervention on maternal outcomes from baseline (22-36 weeks pregnant) to 10 months postpartum. Primary maternal outcomes will include fasting blood glucose and weight (BMI) from baseline to 10 months postpartum. Secondary maternal outcomes will include clinical, adiposity, health behaviors and self-efficacy outcomes from baseline to 10 months postpartum. The third aim of the study is to quantify the effects of the intervention on infant feeding and growth. Infant outcomes will include weight status and breastfeeding from birth through 10 months of age. Data analysis will include general linear mixed-effects models. Safety endpoints include adverse event reporting.Discussion: Findings from this trial may lead to an effective intervention to assist women diagnosed with GDM to improve maternal glucose homeostasis and weight as well as stabilize infant growth trajectory, reducing the burden of metabolic disease across two generations. Trial registration: NCT01809431.

Original languageEnglish (US)
Article number184
JournalBMC Pregnancy and Childbirth
Volume13
DOIs
StatePublished - Oct 10 2013

Fingerprint

Gestational Diabetes
Mothers
Postpartum Period
Prediabetic State
Breast Feeding
Weights and Measures
Type 2 Diabetes Mellitus
Text Messaging
Exercise
Psychological Adaptation
Metabolic Diseases
Health Behavior
Adiposity
Self Efficacy
Growth
Hispanic Americans
African Americans
Blood Glucose
Fasting
Teaching

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Rationale, design, and methodology for the optimizing outcomes in women with gestational diabetes mellitus and their infants study. / Berry, Diane C.; Neal, Madeline; Hall, Emily G.; Schwartz, Todd A.; Verbiest, Sarah; Bonuck, Karen A.; Goodnight, William; Brody, Seth; Dorman, Karen F.; Menard, Mary K.; Stuebe, Alison M.

In: BMC Pregnancy and Childbirth, Vol. 13, 184, 10.10.2013.

Research output: Contribution to journalArticle

Berry, DC, Neal, M, Hall, EG, Schwartz, TA, Verbiest, S, Bonuck, KA, Goodnight, W, Brody, S, Dorman, KF, Menard, MK & Stuebe, AM 2013, 'Rationale, design, and methodology for the optimizing outcomes in women with gestational diabetes mellitus and their infants study', BMC Pregnancy and Childbirth, vol. 13, 184. https://doi.org/10.1186/1471-2393-13-184
Berry, Diane C. ; Neal, Madeline ; Hall, Emily G. ; Schwartz, Todd A. ; Verbiest, Sarah ; Bonuck, Karen A. ; Goodnight, William ; Brody, Seth ; Dorman, Karen F. ; Menard, Mary K. ; Stuebe, Alison M. / Rationale, design, and methodology for the optimizing outcomes in women with gestational diabetes mellitus and their infants study. In: BMC Pregnancy and Childbirth. 2013 ; Vol. 13.
@article{b06ba247ff5c457d9b020ca6a05a917c,
title = "Rationale, design, and methodology for the optimizing outcomes in women with gestational diabetes mellitus and their infants study",
abstract = "Background: Women who are diagnosed with gestational diabetes mellitus (GDM) are at increased risk for developing prediabetes and type 2 diabetes mellitus (T2DM). To date, there have been few interdisciplinary interventions that target predominantly ethnic minority low-income women diagnosed with GDM. This paper describes the rationale, design and methodology of a 2-year, randomized, controlled study being conducted in North Carolina.Methods/Design: Using a two-group, repeated measures, experimental design, we will test a 14- week intensive intervention on the benefits of breastfeeding, understanding gestational diabetes and risk of progression to prediabetes and T2DM, nutrition and exercise education, coping skills training, physical activity (Phase I), educational and motivational text messaging and 3 months of continued monthly contact (Phase II). A total of 100 African American, non-Hispanic white, and bilingual Hispanic women between 22-36 weeks of pregnancy who are diagnosed with GDM and their infants will be randomized to either the experimental group or the wait-listed control group. The first aim of the study is to determine the feasibility of the intervention. The second aim of study is to test the effects of the intervention on maternal outcomes from baseline (22-36 weeks pregnant) to 10 months postpartum. Primary maternal outcomes will include fasting blood glucose and weight (BMI) from baseline to 10 months postpartum. Secondary maternal outcomes will include clinical, adiposity, health behaviors and self-efficacy outcomes from baseline to 10 months postpartum. The third aim of the study is to quantify the effects of the intervention on infant feeding and growth. Infant outcomes will include weight status and breastfeeding from birth through 10 months of age. Data analysis will include general linear mixed-effects models. Safety endpoints include adverse event reporting.Discussion: Findings from this trial may lead to an effective intervention to assist women diagnosed with GDM to improve maternal glucose homeostasis and weight as well as stabilize infant growth trajectory, reducing the burden of metabolic disease across two generations. Trial registration: NCT01809431.",
author = "Berry, {Diane C.} and Madeline Neal and Hall, {Emily G.} and Schwartz, {Todd A.} and Sarah Verbiest and Bonuck, {Karen A.} and William Goodnight and Seth Brody and Dorman, {Karen F.} and Menard, {Mary K.} and Stuebe, {Alison M.}",
year = "2013",
month = "10",
day = "10",
doi = "10.1186/1471-2393-13-184",
language = "English (US)",
volume = "13",
journal = "BMC Pregnancy and Childbirth",
issn = "1471-2393",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Rationale, design, and methodology for the optimizing outcomes in women with gestational diabetes mellitus and their infants study

AU - Berry, Diane C.

AU - Neal, Madeline

AU - Hall, Emily G.

AU - Schwartz, Todd A.

AU - Verbiest, Sarah

AU - Bonuck, Karen A.

AU - Goodnight, William

AU - Brody, Seth

AU - Dorman, Karen F.

AU - Menard, Mary K.

AU - Stuebe, Alison M.

PY - 2013/10/10

Y1 - 2013/10/10

N2 - Background: Women who are diagnosed with gestational diabetes mellitus (GDM) are at increased risk for developing prediabetes and type 2 diabetes mellitus (T2DM). To date, there have been few interdisciplinary interventions that target predominantly ethnic minority low-income women diagnosed with GDM. This paper describes the rationale, design and methodology of a 2-year, randomized, controlled study being conducted in North Carolina.Methods/Design: Using a two-group, repeated measures, experimental design, we will test a 14- week intensive intervention on the benefits of breastfeeding, understanding gestational diabetes and risk of progression to prediabetes and T2DM, nutrition and exercise education, coping skills training, physical activity (Phase I), educational and motivational text messaging and 3 months of continued monthly contact (Phase II). A total of 100 African American, non-Hispanic white, and bilingual Hispanic women between 22-36 weeks of pregnancy who are diagnosed with GDM and their infants will be randomized to either the experimental group or the wait-listed control group. The first aim of the study is to determine the feasibility of the intervention. The second aim of study is to test the effects of the intervention on maternal outcomes from baseline (22-36 weeks pregnant) to 10 months postpartum. Primary maternal outcomes will include fasting blood glucose and weight (BMI) from baseline to 10 months postpartum. Secondary maternal outcomes will include clinical, adiposity, health behaviors and self-efficacy outcomes from baseline to 10 months postpartum. The third aim of the study is to quantify the effects of the intervention on infant feeding and growth. Infant outcomes will include weight status and breastfeeding from birth through 10 months of age. Data analysis will include general linear mixed-effects models. Safety endpoints include adverse event reporting.Discussion: Findings from this trial may lead to an effective intervention to assist women diagnosed with GDM to improve maternal glucose homeostasis and weight as well as stabilize infant growth trajectory, reducing the burden of metabolic disease across two generations. Trial registration: NCT01809431.

AB - Background: Women who are diagnosed with gestational diabetes mellitus (GDM) are at increased risk for developing prediabetes and type 2 diabetes mellitus (T2DM). To date, there have been few interdisciplinary interventions that target predominantly ethnic minority low-income women diagnosed with GDM. This paper describes the rationale, design and methodology of a 2-year, randomized, controlled study being conducted in North Carolina.Methods/Design: Using a two-group, repeated measures, experimental design, we will test a 14- week intensive intervention on the benefits of breastfeeding, understanding gestational diabetes and risk of progression to prediabetes and T2DM, nutrition and exercise education, coping skills training, physical activity (Phase I), educational and motivational text messaging and 3 months of continued monthly contact (Phase II). A total of 100 African American, non-Hispanic white, and bilingual Hispanic women between 22-36 weeks of pregnancy who are diagnosed with GDM and their infants will be randomized to either the experimental group or the wait-listed control group. The first aim of the study is to determine the feasibility of the intervention. The second aim of study is to test the effects of the intervention on maternal outcomes from baseline (22-36 weeks pregnant) to 10 months postpartum. Primary maternal outcomes will include fasting blood glucose and weight (BMI) from baseline to 10 months postpartum. Secondary maternal outcomes will include clinical, adiposity, health behaviors and self-efficacy outcomes from baseline to 10 months postpartum. The third aim of the study is to quantify the effects of the intervention on infant feeding and growth. Infant outcomes will include weight status and breastfeeding from birth through 10 months of age. Data analysis will include general linear mixed-effects models. Safety endpoints include adverse event reporting.Discussion: Findings from this trial may lead to an effective intervention to assist women diagnosed with GDM to improve maternal glucose homeostasis and weight as well as stabilize infant growth trajectory, reducing the burden of metabolic disease across two generations. Trial registration: NCT01809431.

UR - http://www.scopus.com/inward/record.url?scp=84885129331&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885129331&partnerID=8YFLogxK

U2 - 10.1186/1471-2393-13-184

DO - 10.1186/1471-2393-13-184

M3 - Article

VL - 13

JO - BMC Pregnancy and Childbirth

JF - BMC Pregnancy and Childbirth

SN - 1471-2393

M1 - 184

ER -